Global Computer Aided-Drug Discovery Market Size, Trends & Opportunity, By Type (Structure Based Drug Design, Ligand-based Drug Design, Sequence-based Approaches), By Therapeutic Area (Oncology, Neurology, Cardiovascular Disease, Respiratory Disease, Diab

Best Price Guarantee	Publisher	Published Date	SKU
from $3,950	QualiKet Research	December, 2022	QUA17624074

Best Price Guarantee
Price	from $3,950
Publisher	QualiKet Research
Published Date	December, 2022
SKU	QUA17624074

Global Computer Aided-Drug Discovery Market Size, Trends & Opportunity, By Type (Structure Based Drug Design, Ligand-based Drug Design, Sequence-based Approaches), By Therapeutic Area (Oncology, Neurology, Cardiovascular Disease, Respiratory Disease, Diabetes, Others), By End User (Pharmaceutical Companies, Biotechnology Companies, Research Laboratories), By Region & forecast till 2027.

Global Computer Aided-Drug Discovery Market

The Global Computer Aided-Drug Discovery Market is projected to grow from $2.9 billion in 2021 to $4.5 billion by 2027 at a CAGR of over 9.45% during the forecast period that is from 2022-2027.

Computer Aided-Drug Discovery (CADD) is a latest technique in that researchers & analysts use a combination of software to analyse, design, develop, monitor, and study a three-dimensional structure of targeted disease molecule and its complement biomolecule ligand. Computer Aided-Drug Discovery (CADD) is a leading-edge computational method for recognizing & implementing potential leads in drug discovery. CADD is being also used to enhance the quality of leads that have been recognized.

Market Drivers

Rising incidence of Long-term & unknown diseases are anticipated to accelerate demand for fast drug development, driving the Computer Aided-Drug Discovery market growth in the upcoming time period. Strategic affiliation between market players integrate with increasing drug demand are expected to boost the global market. As reported by Premier, inc., a famous healthcare enhancement company the need of novel drug for treatment of CVD conditions has boosted as a result of COVID-19 crises. The facts and figures presented by Premier, inc., show that the demand for the development of new drug molecules is anticipated to growing, which may have a positive impact on the global computer-aided drug discovery market during the analysis period.

Market Restrains

A shortage of skillful labour to operate Computer Aided-Drug Discovery solution may impede global market growth. Lower product penetration in appearing economies is as well hampering drug discovery industry. As computer-aided drug discovery is a modern upgraded technology lots of professionals may either not aware about it or they don’t know how make use of technology to discover drug. Additionally, it is very complicated process which requires skills for operation. People require plenty time to master the use of software. These factors are anticipated to restrain the market growth in future.

Market Segmentation

The Global Computer Aided-Drug Discovery Market is segmented into Type, Therapeutic Area, End user. By Type such as Structure Based Drug Design, Ligand-based Drug Design, Sequence-based Approaches. By Therapeutic Area such as Oncology, Neurology, Cardiovascular Disease, Respiratory Disease, Diabetes, Others. By End user such as Pharmaceutical Companies, Biotechnology Companies, Research Laboratories.

Regional Analysis

The Global Computer Aided-Drug Discovery Market is segmented into five regions North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America computer-aided drug discovery market is expected to bring out maximum revenue during the forecast time period. The Asia-Pacific is projected to grow with the highest CAGR of 12.84% in the forecast period.

Key Players

Various Key Players are listed in this report such as Aris Pharmaceuticals, Inc, Charles River Laboratories, Aragon Life Sciences Pvt. Ltd., Bayer AG, Schrödinger, Inc., AstraZeneca, Bioduro-Sundia,Albany Molecular Research Inc. (AMRI), BOCSCI Inc.

Market Taxonomy

By Type

Structure Based Drug Design
Ligand-based Drug Design
Sequence-based Approaches.

By Therapeutic area

Oncology
Neurology
Cardiovascular Disease
Respiratory Disease
Diabetes
Others.

By End User

Pharmaceutical Companies
Biotechnology Companies
Research Laboratories.

By Region

North America
Latin America
Europe
Asia Pacific
Middle East & Africa.

1 Introduction: 1.1 Objective of the Study; 1.2 Market definition; 1.3 Market Scope
2 Research Methodology: 2.1 Data Mining; 2.2 Validation; 2.3 Primary Interviews; 2.4 List of Data Sources
3 Executive Summary
4 Global Computer Aided-Drug Discovery Market Outlook: 4.1 Overview; 4.2 Market Dynamics; 4.2.1 Drivers; 4.2.2 Restraints; 4.2.3 Opportunities; 4.3 Porters Five Force Model; 4.4 Value Chain Analysis
5 Global Computer Aided-Drug Discovery Market, By Type: 5.1 Y-o-Y Growth Comparison, By Type; 5.2 Global Computer Aided-Drug Discovery Market Share Analysis, By Type; 5.3 Global Computer Aided-Drug Discovery Market Size and Forecast, By Type; 5.3.1 Radioimmunoassay (RIA); 5.3.2 Enzyme Immunoassays (EIA); 5.3.3 Rapid Test; 5.3.4 Others
6 Global Computer Aided-Drug Discovery Market, By Type: 6.1 Y-o-Y Growth Comparison, By Type; 6.2 Global Computer Aided-Drug Discovery Market Share Analysis, By Type; 6.3 Global Computer Aided-Drug Discovery Market Size and Forecast, By Type; 6.3.1 Structure Based Drug Design; 6.3.2 Ligand-based Drug Design; 6.3.3 Sequence-based Approaches.
7 Global Computer Aided-Drug Discovery Market, By Therapeutic Area: 7.1 Y-o-Y Growth Comparison, By Therapeutic Area; 7.2 Global Computer Aided-Drug Discovery Market Share Analysis, By Therapeutic Area; 7.3 Global Computer Aided-Drug Discovery Market Size and Forecast, By Therapeutic Area; 7.3.1 Oncology; 7.3.2 Neurology; 7.3.3 cardiovascular disease; 7.3.4 respiratory disease; 7.3.5 Diabetes; 7.3.6 Others.
8 Global Computer Aided-Drug Discovery Market, By End-user: 8.1 Y-o-Y Growth Comparison, By End-use; 8.2 Global Computer Aided-Drug Discovery Market Share Analysis, By End-user; 8.3 Global Computer Aided-Drug Discovery Market Size and Forecast, By End-user; 8.3.1 Pharmaceutical Companies; 8.3.2 Biotechnology Companies; 8.3.3 Research Laboratories
9 Global Computer Aided-Drug Discovery Market, By Region: 9.1 Global Computer Aided-Drug Discovery Market Share Analysis, By Region; 9.2 Global Computer Aided-Drug Discovery Market Share Analysis, By Region; 9.3 Global Computer Aided-Drug Discovery Market Size and Forecast, By Region
10 North America Computer Aided-Drug Discovery Analysis and Forecast (2022-2027): 10.1 Introduction; 10.2 North America Computer Aided-Drug Discovery Share Analysis, By Type; 10.3 North America Computer Aided-Drug Discovery Size and Forecast, By Therapeutic Area; 10.4 North America Computer Aided-Drug Discovery Size and Forecast, By End-use; 10.6 North America Computer Aided-Drug Discovery Size and Forecast, By Country; 10.7.1 U.S.; 10.7.2 Canada; 10.7.3 Mexico
11 Europe Computer Aided-Drug Discovery Analysis and Forecast (2022-2027): 11.1 Introduction; 11.2 Europe Computer Aided-Drug Discovery Share Analysis, By Type; 11.3 Europe Computer Aided-Drug Discovery Size and Forecast, By Therapeutic Area; 11.4 Europe Computer Aided-Drug Discovery Size and Forecast, By End-use; 11.6 Europe Computer Aided-Drug Discovery Size and Forecast, By Country; 11.6.1 Germany; 11.6.2 France; 11.6.3 UK; 11.6.4. Rest of Europe
12 Asia Pacific Computer Aided-Drug Discovery Analysis and Forecast (2022-2027): 12.1 Introduction; 12.2 Asia Pacific Computer Aided-Drug Discovery Share Analysis, By Type; 12.3 Asia Pacific Computer Aided-Drug Discovery Size and Forecast, By Therapeutic Area; 12.4 Asia Pacific Computer Aided-Drug Discovery Size and Forecast, By End-use; 12.6 Asia Pacific Computer Aided-Drug Discovery Size and Forecast, By Country; 12.6.1 China; 12.7.2 Japan; 12.8.3 India; 12.8.4. Rest of Asia Pacific
13 Latin America Computer Aided-Drug Discovery Analysis and Forecast (2022-2027): 13.1 Introduction; 13.2 Latin America Computer Aided-Drug Discovery Share Analysis, By Type; 13.3 Latin America Computer Aided-Drug Discovery Size and Forecast, By Therapeutic Area; 13.4 Latin America Computer Aided-Drug Discovery Size and Forecast, By End-use; 13.6 Latin America Computer Aided-Drug Discovery Size and Forecast, Country; 13.7.1. Brazil; 13.8.2. Rest of Latin America
14 Middle East Computer Aided-Drug Discovery Analysis and Forecast (2022-2027): 14.1 Introduction; 14.2 Middle East Computer Aided-Drug Discovery Share Analysis, By Type; 14.3 Middle East Computer Aided-Drug Discovery Size and Forecast, By Therapeutic Area; 14.4 Middle East Computer Aided-Drug Discovery Size and Forecast, By End-use; 14.6 Middle East Computer Aided-Drug Discovery Size and Forecast, By Country; 14.7.1. Saudi Arabia; 14.8.2. UAE; 14.8.3. Egypt; 14.9.4. Kuwait; 14.10.5. South Africa
15 Competitive Analysis: 15.1 Competition Dashboard; 15.2 Market share Analysis of Top Vendors; 15.3 Key Development Strategies
16 Company Profiles: 16.1 Aris Pharmaceuticals, Inc; 16.1.1 Overview; 16.1.2 Products; 16.1.3 Key Financials; 16.1.4 Business Segment & Geographic Overview; 16.1.5 Key Market Developments; 16.1.6 Key Strategies; 16.2 Charles River Laboratories; 16.2.1 Overview; 16.2.2 Products; 16.2.3 Key Financials; 16.2.4 Business Segment & Geographic Overview; 16.2.5 Key Market Developments; 16.2.6 Key Strategies; 16.3 Aragon Life Sciences Pvt. Ltd; 16.3.1 Overview; 16.3.2 Products; 16.3.3 Key Financials; 16.3.4 Business Segment & Geographic Overview; 16.3.5 Key Market Developments; 16.3.6 Key Strategies; 16.4 Bayer AG, Schrödinger, Inc; 16.4.1 Overview; 16.4.2 Products; 16.4.3 Key Financials; 16.4.4 Business Segment & Geographic Overview; 16.4.5 Key Market Developments; 16.4.6 Key Strategies; 16.5 AstraZeneca; 16.5.1 Overview; 16.5.2 Products; 16.5.3 Key Financials; 16.5.4 Business Segment & Geographic Overview; 16.5.5 Key Market Developments; 16.5.6 Key Strategies; 16.6 Bioduro-Sundia; 16.6.1 Overview; 16.6.2 Products; 16.6.3 Key Financials; 16.6.4 Business Segment & Geographic Overview; 16.6.5 Key Market Developments; 16.6.6 Key Strategies; 16.7 Albany Molecular Research Inc. (AMRI); 16.7.1 Overview; 16.7.2 Products; 16.7.3 Key Financials; 16.7.4 Business Segment & Geographic Overview; 16.7.5 Key Market Developments; 16.7.6 Key Strategies; 16.8 BOCSCI Inc.; 16.8.1 Overview; 16.8.2 Products; 16.8.3 Key Financials; 16.8.4 Business Segment & Geographic Overview; 16.8.5 Key Market Developments; 16.8.6 Key Strategies